Tag: Prescription Drugs
Hydroxychloroquine Plus Macrolides No Benefit in COVID-19
Hydroxychloroquine, chloroquine with or without macrolides linked to in-hospital mortality, arrhythmia
Guideline Details Pharmacologic Management of COPD
Clinical practice guideline addresses six emerging questions around COPD management
Long-Term Rituximab May Aid in Antibody-Associated Vasculitis
Relapse rates lower versus placebo in granulomatosis with polyangiitis, microscopic polyangiitis
Hydroxychloroquine Prescriptions Surge in U.S. During Pandemic
Increase in hydroxychloroquine/chloroquine fills seen during week of March 15 to 21, 2020
Adherence to Diabetes Meds May Cut Mortality in Colorectal Cancer
Patients with colorectal cancer and diabetes have better survival with adherence to diabetes meds
Human Trial of Antibody Therapy to Treat COVID-19 Underway
If drug proves safe and effective, it could be available for use by the fall
ASCO: Relugolix Superior to Leuprolide in Advanced Prostate Cancer
And, enzalutamide improves median overall survival in nonmetastatic, castration-resistant prostate cancer
Five-Day Course of Remdesivir Beneficial in Severe COVID-19
No significant difference seen in five-, 10-day course for severe COVID-19 without mechanical ventilation
Remdesivir Use Growing Globally in COVID-19 Patients
Yet, most physicians believe it is only moderately effective, better used earlier than official guidelines recommend
VA Slashes Use of Hydroxychloroquine to Treat COVID-19 Patients
Prescribing reduced to just three prescriptions in the last week as new research highlights possible dangers
